Navigation Links
New Treatment Offers Hope for Beating Aggressive Cancers
Date:4/28/2008

NASHVILLE, Tenn., April 29 /PRNewswire/ -- With an 89% initial success rate in arresting or eradicating some of the most aggressive cancers, a Nashville-based treatment is being offered to the public for the first time. According to NeoPlas Innovation Director of Research Dr. Stephen Cantrell, gathering more data to validate effectiveness is imperative, but "early human results are quite exciting. This treatment has been effective for malignant melanoma, as well as pancreatic and some of the other worst-prognosis cancers."

The new protocol incorporates a unique combination of FDA-approved drugs already known to be safe, each used by millions of people for other applications. When administered alone, these drugs show some benefit against cancer, but not enough to make a difference for most patients. The combination of the medicines, however, allows lower, more tolerable dosages and provides effectiveness not seen in previous single-drug studies.

The NeoPlas treatment shows benefit in several aggressive malignancies because it disables certain abnormal cellular processes many of them share. Based on experience and relevant lab research to date, staff members expect the best results for melanoma, pancreatic cancer, colon cancer, renal (kidney) cancer, mesothelioma, and a group of sarcomas, including osteosarcoma, chondrosarcoma and malignant fibrous histiocytoma. Patients who have other cancers can be considered on a case-by-case basis, since many of them may benefit also. Having received previous cancer treatments does not make a patient ineligible.

The regimen's most notable side-effect is fatigue. Most patients never experience nausea, vomiting, hair loss, bone marrow or immune system suppression, or other side-effects commonly affiliated with chemotherapy or radiation. An experienced physician prescribes and monitors all treatment and maintains close communication with the patient's established oncologist.

NeoPlas Innovation serves patients living throughout the country. Since treatment takes place on an outpatient basis, most patients travel to Nashville about once every two months. Additionally, physicians usually can tell if the program is working within eight weeks and quickly enable patients to make their best healthcare decisions.

NeoPlas Innovation's web site, http://www.neoplas.org , provides complete information and an interactive screening tool for patients who are considering this treatment. The center can be reached by calling 615-371-8100 or e-mailing office@neoplas.org.


'/>"/>
SOURCE NeoPlas Innovation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dental Convention to Highlight Latest Breakthroughs in Oral Health Treatments
2. Study shows false memories complicate end-of-life treatment decisions
3. HHS, Cleveland Clinic Collaborate to Advance Treatment for Neurological Disorders
4. Autistic mannerisms reduced by sensory treatment
5. Mutation database helps personalized treatment of lung cancer
6. UCB Launches CIMplicity(TM) Program to Enhance Treatment Support for Cimzia(R) (certolizumab pegol) Patients and Caregivers
7. ACTwatch, to Improve Malaria Treatment, to Be Launched on World Malaria Day
8. Study finds racial disparities in smoking cessation treatment
9. Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability
10. Annual Trachoma Treatments May Be Unnecessary
11. Discovery to hasten new malaria treatments, vaccines for children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology: